BIO International Convention
From June 5 to 8, ZoBio will participate in BIO International Convention in Boston. This intensive four-day event, attracts around 14,000+ biotechnology and pharma leaders ready to discover new business opportunities and promising partnerships.
During the entire event Michael Nyman, our Director Business Development will participate in One-on-One meetings, reaching out to more than 15 decision makers in one day. This way, he can efficiently inform them about our services and recent developments at ZoBio.
ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023
From 10 to 13 June Michael Nyman will attend ACSMEDI-EFMC Medicinal Chemistry Frontiers symposium in Boston. The conference is co-organized as a collaboration between the ACS (American Chemical Society), MEDI (Division of Medicinal Chemistry) and the EFMC (European Federation for Medicinal Chemistry and Chemical Biology).
The meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
Looking forward to meeting you there!
RICT 2023: 57th International Conference on Medicinal Chemistry
ZoBio will be present in Lille at 57th International Conference on Medicinal Chemistry. The event is organized yearly by the French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT).
As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific program.
ZoBio will be represented by Anna Belorusova, Senior Scientist from Assay Development and Screening group. She will present the poster describing the complementarity between nanoDSF/DLS and SPR to minimize assay artifacts arising from compound and protein aggregation. Anna will be joined by Kasia Borsuk, Business Development Manager. They will gladly discuss how modern biophysics can be applied to your drug discovery projects.
We are looking forward to participate in the conference, ready to share our knowledge and hear many inspiring medicinal chemistry stories!
Drug Discovery Chemistry
Over the past years Cambridge Healthtech Institute’s Annual Drug Discovery Chemistry has grown to one of the largest events for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists. ZoBio is therefore proud to actively participate in this event.
This year, one of our scientists Pim de Vink presented the poster “Dissecting Molecular Glues with Biophysics”. He was supported by Jan Schultz and Micheal Nyman, our Business Development team, who gladly answered questions from the attendees about ZoBio and our various services.
SMR Meeting: Molecular Glues
Molecular glues and targeted protein degraders are changing the landscape of drug discovery. They show great potential for treating diseases such as cancer, infectious, inflammatory, and
neurodegenerative diseases, especially for those with “undruggable” pathogenic protein targets. With the
recent rise of the ‘molecular glue’ type of protein degraders, new therapies for unmet medical needs are being designed and developed.
Reflecting the excitement surrounding this new modality, the Society for Medicines Research organized a one day meeting at the GSK Campus (Stevenage, UK) focused on the theme of Molecular Glues.
Leading speakers from academia and industry outlined recent advances in the field. Presentations varied from glue discovery and their application as drugs to the cell biology underpinning the molecular glue concept.
ZoBio attended the meeting for the second time and was proud to be a gold sponsor of the event.
16th Winter Conference on Medicinal & Bioorganic Chemistry
ZoBio was attending 16th Winter Conference on Medicinal & Bioorganic Chemistry held in the beautiful Steamboat Springs Resort, Colorado.
The conference exposed attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery.
In addition to the scientific presentations, this meeting provided a great opportunity for attendees to informally interact and strengthen their scientific network.